Neuberger Berman Group LLC Teva Pharmaceutical Industries LTD Transaction History

Neuberger Berman Group LLC

  • $121 Billion
  • Q4 2024

A detailed history of Neuberger Berman Group LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Neuberger Berman Group LLC holds 29,398 shares of TEVA stock, worth $492,122. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,398
Previous 3,914,070 99.25%
Holding current value
$492,122
Previous $70.5 Million 99.08%
% of portfolio
0.0%
Previous 0.06%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$16.43 - $22.77 $63.8 Million - $88.5 Million
-3,884,672 Reduced 99.25%
29,398 $647,000
Q3 2024

Nov 14, 2024
BUY
$15.81 - $18.96 $380,720 - $456,575
24,081 Added 0.62%
3,914,070 $70.5 Million
Q2 2024

Nov 14, 2024
SELL
$12.78 - $17.4 $1.79 Million - $2.43 Million
-139,727 Reduced 3.47%
3,889,989 $63.2 Million
Q2 2024

Aug 13, 2024
SELL
$12.78 - $17.4 $1.79 Million - $2.43 Million
-139,727 Reduced 3.47%
3,889,989 $63.2 Million
Q1 2024

Nov 14, 2024
BUY
$10.67 - $14.43 $42.7 Million - $57.8 Million
4,004,205 Added 15695.99%
4,029,716 $56.9 Million
Q1 2024

May 13, 2024
BUY
$10.67 - $14.43 $43 Million - $58.1 Million
4,029,716 New
4,029,716 $56.9 Million
Q4 2023

Nov 14, 2024
SELL
$8.12 - $10.63 $31.4 Million - $41.1 Million
-3,864,478 Reduced 99.34%
25,511 $266,000
Q4 2023

Feb 09, 2024
BUY
$8.12 - $10.63 $77,416 - $101,346
9,534 Added 59.67%
25,511 $266,000
Q3 2023

Nov 14, 2023
BUY
$7.48 - $10.7 $119,507 - $170,953
15,977 New
15,977 $162,000
Q2 2020

Aug 13, 2020
BUY
$8.12 - $13.12 $1.14 Million - $1.85 Million
140,933 Added 8.93%
1,718,494 $21.2 Million
Q1 2020

May 14, 2020
BUY
$6.69 - $13.45 $10.6 Million - $21.2 Million
1,577,561 New
1,577,561 $14.2 Million
Q3 2019

Nov 13, 2019
SELL
$6.16 - $9.6 $229,386 - $357,484
-37,238 Closed
0 $0
Q2 2019

Aug 13, 2019
SELL
$8.12 - $15.72 $4.72 Million - $9.13 Million
-581,014 Reduced 93.98%
37,238 $344,000
Q1 2019

May 13, 2019
BUY
$15.58 - $20.01 $383,127 - $492,065
24,591 Added 4.14%
618,252 $9.69 Million
Q4 2018

Feb 12, 2019
SELL
$14.59 - $23.84 $61,073 - $99,794
-4,186 Reduced 0.7%
593,661 $9.15 Million
Q3 2018

Nov 13, 2018
SELL
$21.06 - $25.65 $189 - $230
-9 Reduced -0.0%
597,847 $12.9 Million
Q2 2018

Aug 13, 2018
BUY
$16.77 - $24.71 $33,992 - $50,087
2,027 Added 0.34%
597,856 $14.5 Million
Q1 2018

May 08, 2018
BUY
$16.68 - $22.07 $18,214 - $24,100
1,092 Added 0.18%
595,829 $10.2 Million
Q4 2017

Feb 14, 2018
SELL
$11.23 - $19.1 $1.05 Million - $1.79 Million
-93,804 Reduced 13.62%
594,737 $11.3 Million
Q3 2017

Nov 15, 2017
BUY
$15.41 - $32.17 $10.6 Million - $22.2 Million
688,541
688,541 $12.1 Million

Others Institutions Holding TEVA

# of Institutions
674
Shares Held
578M
Call Options Held
25.5M
Put Options Held
14.7M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.6B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email